Literature DB >> 16498090

Focal parenchymal lung lesions showing a potential of false-positive and false-negative interpretations on integrated PET/CT.

Sung Shine Shim1, Kyung Soo Lee, Byung-Tae Kim, Joon Young Choi, Myung Jin Chung, Eun Jeong Lee.   

Abstract

OBJECTIVE: We describe a number of benign focal lung lesions with increased 18F-FDG uptake that simulate lung cancer and malignant lesions that lead to false-negatives due to little 18F-FDG uptake on integrated PET/CT images.
CONCLUSION: The integration of clinical history, morphologic findings of lung parenchymal lesions on the CT component, and metabolic activities on the PET component of integrated PET/CT can help reduce false interpretation of the study. A lung biopsy may be needed for lesions showing increased 18F-FDG uptake on PET for tissue confirmation irrespective of their morphology on CT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498090     DOI: 10.2214/AJR.04.1896

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  19 in total

1.  Role of positron emission tomography-computed tomography in bronchial mucoepidermoid carcinomas: a case series and review of the literature.

Authors:  Tarun Jindal; Arvind Kumar; Rakesh Kumar; Roman Dutta; Monika Meena
Journal:  J Med Case Rep       Date:  2010-08-19

2.  Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.

Authors:  Guohua Shen; Zhiyun Jia; Houfu Deng
Journal:  Eur Radiol       Date:  2015-05-24       Impact factor: 5.315

3.  Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).

Authors:  Tomoko Hirakawa; Jun Kato; Yoshihiro Okumura; Keisuke Hori; Sakuma Takahashi; Hideyuki Suzuki; Mitsuhiro Akita; Reiji Higashi; Shunsuke Saito; Eisuke Kaji; Toshio Uraoka; Sakiko Hiraoka; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

4.  System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid.

Authors:  Weiping Yu; Jonathan McConathy; Jeffrey J Olson; Mark M Goodman
Journal:  Nucl Med Biol       Date:  2014-08-01       Impact factor: 2.408

5.  Wedge resection for localized infectious lesions: high margin/lesion ratio guaranteed operational safety.

Authors:  Yifeng Sun; Likun Hou; Huikang Xie; Hui Zheng; Gening Jiang; Wen Gao; Chang Chen
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

6.  Pulmonary actinomycosis: the great masquerader.

Authors:  Hussam Elkambergy; Farzan Irani; Kelechi Okoli; Raheel Jamal
Journal:  BMJ Case Rep       Date:  2009-02-16

7.  Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial.

Authors:  Sandra Pauls; Andreas K Buck; Gisela Halter; Felix M Mottaghy; Rainer Muche; Christina Bluemel; Susanne Gerstner; Stefan Krüger; Gerhard Glatting; Ludger Sunder-Plassmann; Peter Möller; Hans-Jürgen Brambs; Sven N Reske
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

8.  Pulmonary cryptococcosis: imaging findings in 23 non-AIDS patients.

Authors:  Kyoung Doo Song; Kyung Soo Lee; Man Pyo Chung; O Jung Kwon; Tae Sung Kim; Chin A Yi; Myung Jin Chung
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

9.  Diffusion Weighted Magnetic Resonance Imaging for the Characterization of Solitary Pulmonary Lesions.

Authors:  Çağlayan Çakır; Hakan Gençhellaç; Osman Temizöz; Ahmet Polat; Ersin Şengül; Gökhan Duygulu
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

Review 10.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.